Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54497

1.

Hoarding disorder: a medical condition.

Burki T.

Lancet. 2018 Aug 25;392(10148):626. doi: 10.1016/S0140-6736(18)31983-4. No abstract available.

PMID:
30152334
2.

[Emotion dysregulation and psychopathology in epilepsy].

Bazarnik A.

Pol Merkur Lekarski. 2018 Jun 27;44(264):302-307. Review. Polish.

PMID:
30057400
3.
4.

Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A.

Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966. Review.

PMID:
30056792
5.

Efficacy and tolerability of fluvoxamine in adults with social anxiety disorder: A meta-analysis.

Liu X, Li X, Zhang C, Sun M, Sun Z, Xu Y, Tian X.

Medicine (Baltimore). 2018 Jul;97(28):e11547. doi: 10.1097/MD.0000000000011547. Review.

6.

Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.

Purgato M, Gastaldon C, Papola D, van Ommeren M, Barbui C, Tol WA.

Cochrane Database Syst Rev. 2018 Jul 5;7:CD011849. doi: 10.1002/14651858.CD011849.pub2. Review.

PMID:
29975811
7.

Depression and anxiety disorders among patients with human T-cell lymphotropic virus type-1: a cross-sectional study with a comparison group.

Rocha-Filho PAS, Goncalves LR.

Rev Soc Bras Med Trop. 2018 May-Jun;51(3):357-360. doi: 10.1590/0037-8682-0365-2016.

8.

Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study.

Rezapour J, Nickels S, Schuster AK, Michal M, Münzel T, Wild PS, Schmidtmann I, Lackner K, Schulz A, Pfeiffer N, Beutel ME.

BMC Ophthalmol. 2018 Jun 28;18(1):157. doi: 10.1186/s12886-018-0831-1.

9.

Pharmacological interventions for anxiety in Parkinson's disease sufferers.

Sawada H, Umemura A, Kohsaka M, Tomita S, Park K, Oeda T, Yamamoto K.

Expert Opin Pharmacother. 2018 Jul;19(10):1071-1076. doi: 10.1080/14656566.2018.1485650. Epub 2018 Jun 25. Review.

PMID:
29939821
10.

Influence of Pb and Cd levels in whole blood of postmenopausal women on the incidence of anxiety and depressive symptoms.

Jurczak A, Brodowska A, Szkup M, Prokopowicz A, Karakiewicz B, Łój B, Kotwas A, Brodowska A, Grochans E.

Ann Agric Environ Med. 2018 Feb 28;25(2):219-223. doi: 10.26444/aaem/85929. Epub 2018 Feb 28.

11.

Lack of group-to-individual generalizability is a threat to human subjects research.

Fisher AJ, Medaglia JD, Jeronimus BF.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6106-E6115. doi: 10.1073/pnas.1711978115. Epub 2018 Jun 18.

PMID:
29915059
12.

Pituitary gland volumes in patients with obsessive-compulsive disorder before and after cognitive-behavioral therapy.

Atmaca M, Yildirim H, Yilmaz S, Caglar N, Baykara S, Kekilli Y, Koseoglu F, Turkcapar H.

Rev Bras Psiquiatr. 2018 Oct-Dec;40(4):420-423. doi: 10.1590/1516-4446-2017-2449. Epub 2018 Jun 11.

13.

Obsessive-compulsive symptoms in children with first degree relatives diagnosed with obsessive-compulsive disorder.

Chacon P, Bernardes E, Faggian L, Batistuzzo M, Moriyama T, Miguel EC, Polanczyk GV.

Rev Bras Psiquiatr. 2018 Oct-Dec;40(4):388-393. doi: 10.1590/1516-4446-2017-2321. Epub 2018 Jun 11.

14.

[CME: Fear of Flying and Flying Phobia].

Schindler B.

Praxis (Bern 1994). 2018 Jun;107(12):623-628. doi: 10.1024/1661-8157/a002980. Review. German.

PMID:
29871581
15.

Positive response to clozapine augmentation in a patient with obsessive-compulsive disorder complicated by a tardive movement disorder.

Baptista T, de Leon J.

Rev Bras Psiquiatr. 2018 Jun;40(2):229-230. doi: 10.1590/1516-4446-2017-2565. No abstract available.

16.

Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.

Gomez AF, Barthel AL, Hofmann SG.

Expert Opin Pharmacother. 2018 Jun;19(8):883-894. doi: 10.1080/14656566.2018.1472767. Epub 2018 May 28. Review.

17.

The impact of maternal anxiety disorder on mother-infant interaction in the postpartum period.

Reck C, Tietz A, Müller M, Seibold K, Tronick E.

PLoS One. 2018 May 25;13(5):e0194763. doi: 10.1371/journal.pone.0194763. eCollection 2018.

18.

Treatment of depression and/or anxiety - outcomes of a randomised controlled trial of the tree theme method® versus regular occupational therapy.

Birgitta Gunnarsson A, Wagman P, Hedin K, Håkansson C.

BMC Psychol. 2018 May 23;6(1):25. doi: 10.1186/s40359-018-0237-0.

19.

Awareness of and phobias about topical corticosteroids in parents of infants with eczema in Hangzhou, China.

Li Y, Han T, Li W, Li Y, Guo X, Zheng L.

Pediatr Dermatol. 2018 Jul;35(4):463-467. doi: 10.1111/pde.13527. Epub 2018 May 22.

PMID:
29786146
20.

Migraine and temporomadibular disorders.

Speciali JG.

Arq Neuropsiquiatr. 2018 Apr;76(4):211-212. doi: 10.1590/0004-282x20180034. No abstract available.

Supplemental Content

Loading ...
Support Center